FDA: Do not use sterile products made by Houston compounding pharmacy

Health care providers and patients should not use compounded products marketed as sterile by Greenpark Compounding Pharmacy due to a lack of sterility assurance, the Food and Drug Administration announced today. FDA recently recommended the compounder expand its recall of a compounded ophthalmic drug to include all unexpired compounded drugs intended to be sterile and stop their production until it implements adequate corrective actions. However, the company has refused to recall the products or cease compounding sterile drugs, FDA said.
Related News Articles
Headline
The Food and Drug Administration has issued early alerts for certain Spectrum infusion pumps from Baxter and Abiomed Automated Impella Controllers. The agency…
Headline
The Food and Drug Administration has approved a new, first-of-its-kind semiannual HIV prevention medication, Gilead Sciences announced June 18. The company…
Headline
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China. The tariffs for Mexico and Canada have since been delayed…
Headline
The Food and Drug Administration is evaluating Chinese-made plastic syringes used to inject or withdraw fluids from the body, citing concern that they may…
Headline
Draeger Medical, Inc. is recalling its Carina Ventilators due to the presence of contaminants in the device’s airpath, which exceed acceptable levels if…
Headline
Crews are working to restore power and assess damage to a Pfizer plant in North Carolina that makes sterile injectables for U.S. hospitals after a tornado…